Clemensia Nakabiito

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial”.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1872

N/A

2.5DataRank · unranked

63 citations

Peter L. Anderson, Deborah Kacanek, Sybil Hosek, Sharon Huang, Teacler Nematadzira +32 more

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

The Lancet HIV(2021)10.1016/s2352-3018(20)30304-0

N/A

2.4DataRank · unranked

111 citations

Thesla Palanee‐Phillips, Nyaradzo Mgodi, Ashley Mayo, Daniel Szydlo, Gita Ramjee +91 more

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00227-8

N/A

1.8DataRank · unranked

62 citations

Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne A. Akello, Rita Nakalega +28 more

Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial

BMC Infectious Diseases(2021)10.1186/s12879-021-06608-4

N/A

0.920DataRank · unranked

23 citations

Gordon Rukundo, Alexander Amone, Priscilla Wavamunno, Joyce Namale-Matovu, Irene Lubega +9 more

Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial

PLoS ONE(2024)10.1371/journal.pone.0297652

N/A

0.527DataRank · unranked

11 citations

Grace Gabagaya, Priscilla Wavamunno, Gordon Rukundo, Joyce Namale-Matovu, Samuel S. Malamba +8 more

Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

The Lancet HIV(2025)10.1016/s2352-3018(25)00261-9

N/A

0.208DataRank · unranked

3 citations

Daniel Szydlo, Ashley Mayo, Katie Bunge, Felix Mhlanga, Jeanna Piper +57 more

DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003312

N/A

0DataRank · unranked

34 citations

Jennifer E. Balkus, Lee Fairlie, Ashley Mayo, Clemensia Nakabiito, Nyaradzo Mgodi +9 more

Metabolomic profiling of preterm birth in pregnant women living with HIV

Metabolomics(2023)10.1007/s11306-023-02055-1

N/A

0DataRank · unranked

4 citations

Aisling Murphy, Fan Li, Sean S. Brummel, Mary Glenn Fowler, James McIntyre +10 more

Enhanced Peer-Group strategies to support prevention of Mother-to-Child HIV transmission leads to increased retention in care in Uganda: A Randomized controlled trial

medRxiv(2023)10.1101/2023.04.15.23288495

N/A

0DataRank · unranked

2 citations

Grace Gabagaya, Priscilla Wavamunno, Gordon Rukundo, Joyce Namale-Matovu, Samuel S. Malamba +8 more

Correlates of long-acting reversible contraceptive (LARC) use among young women in Southern Africa: a secondary analysis from HPTN 082

medRxiv(2025)10.1101/2025.09.16.25335943

N/A

0DataRank · unranked

0 citations

Michael Burton, Brenda Gati Mirembe, Clemensia Nakabiito, Deborah Donnell, Geetha Beauchamp +4 more

Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review

PLoS ONE(2021)10.1371/journal.pone.0248423

N/A

0DataRank · unranked

17 citations

Moni B. Neradilek, Lee Fairlie, Bonus Makanani, Nyaradzo Mgodi, Felix Mhlanga +7 more

Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe

AIDS and Behavior(2022)10.1007/s10461-022-03713-6

N/A

0DataRank · unranked

20 citations

Juliane Etima, Petina Musara, Erica N. Browne, Prisca Mutero, Doreen Kemigisha +9 more

Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda

The Lancet Global Health(2022)10.1016/s2214-109x(22)00080-8

N/A

0DataRank · unranked

18 citations

Noah Kiwanuka, Martin Nabwana, Delia Scholes, Philippa Musoke, Mary Glenn Fowler +82 more

Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial

AIDS and Behavior(2022)10.1007/s10461-022-03841-z

N/A

0DataRank · unranked

4 citations

Maria Valdez Cabrera, Ariane van der Straten, Rita Nakalega, Mandy Rae Cobbing, Nyaradzo Mgodi +13 more

Couples’ decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention

AIDS and Behavior(2022)10.1007/s10461-022-03756-9

N/A

0DataRank · unranked

5 citations

Erica N. Browne, Juliane Etima, Petina Musara, Miriam Hartmann, Mary Kate Shapley‐Quinn +9 more

HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial

African Health Sciences(2022)10.4314/ahs.v22i4.48

N/A

0DataRank · unranked

3 citations

Priscilla Wavamunno, Grace Gabagaya, Gordon Rukundo, Joyce Namale-Matovu, Samuel S. Malamba +8 more